Bachelot Anne, Nicolas Carole, Gricourt Solenne, Dulon Jérôme, Leban Monique, Golmard Jean Louis, Touraine Philippe
AP-HP, IE3M, Hôpital Pitié-Salpêtrière, Department of Endocrinology and Reproductive Medicine, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Centre de Référence des Pathologies Gynécologiques Rares, Paris, France.
Université Pierre et Marie Curie, Univ Paris, Paris, France.
PLoS One. 2016 Dec 1;11(12):e0164638. doi: 10.1371/journal.pone.0164638. eCollection 2016.
Premature ovarian insufficiency leads to through infertility and estrogen deficiency. Optimal management encompasses estrogen replacement therapy. Long-term outcome of women with POI is not known. We design a study to evaluate the medical care, hormone replacement therapy compliance and bone mineral density (BMD) in POI women with at least a five-year follow-up after the first evaluation. One hundred and sixty-two patients (37.3±8.0 years) were evaluated (follow-up 7.9±2.8 years). Sixty-nine patients (42.6%) had stopped their hormone replacement therapy (HRT) for at least one year during the follow up period. BMD determination at initial evaluation and at follow-up visit was completed in 92 patients. At first evaluation, 28 patients (30%) had osteopenia and 7 (8%) had osteoporosis. At follow up, 31 women (34%) had BMD impairment with osteopenia in 61% and osteoporosis in 5%. In univariate analysis and multivariate analysis, there was a significant loss of femoral BMD in women who had stopped their HRT for over a year. In conclusion, this first study concerning long-term follow-up of POI patients shows the poor compliance to their HRT, despite its importance in the prevention of bone demineralization. This study reinforces the need for follow up and specific care for POI women.
卵巢早衰会导致彻底不孕和雌激素缺乏。最佳治疗方案包括雌激素替代疗法。卵巢早衰女性的长期预后尚不清楚。我们设计了一项研究,以评估卵巢早衰女性在首次评估后至少随访五年的医疗护理、激素替代疗法依从性和骨矿物质密度(BMD)。对162例患者(37.3±8.0岁)进行了评估(随访7.9±2.8年)。69例患者(42.6%)在随访期间停止激素替代疗法(HRT)至少一年。92例患者完成了首次评估和随访时的骨密度测定。首次评估时,28例患者(30%)有骨量减少,7例(8%)有骨质疏松症。随访时,31例女性(34%)有骨密度损害,其中61%为骨量减少,5%为骨质疏松症。单因素分析和多因素分析显示,停止激素替代疗法超过一年的女性股骨骨密度有显著损失。总之,这项关于卵巢早衰患者长期随访的首次研究表明,尽管激素替代疗法对预防骨质脱矿很重要,但患者对其依从性较差。这项研究强化了对卵巢早衰女性进行随访和特殊护理的必要性。